Jon Cuccui

This inventor holds 1 USPTO granted patent. Top assignee: London School of Hygiene and Tropical Medicine. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jon Cuccui. Retrieved from https://idiyas.com/inventor/jon-cuccui-qau1353r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jon Cuccui: Innovator in Glyconjugate Vaccines

Introduction

Jon Cuccui is a notable inventor recognized for his contributions to the field of vaccine development. He is currently associated with the London School of Hygiene and Tropical Medicine, where he focuses on innovative solutions to combat infectious diseases. His work is pivotal in advancing public health through scientific research and innovation.

Latest Patents

Jon Cuccui holds a patent for Glyconjugate Vaccines. This invention represents a significant advancement in vaccine technology, aimed at improving the efficacy and safety of vaccines against various pathogens. His patent is a testament to his commitment to enhancing global health through innovative research.

Career Highlights

Throughout his career, Jon Cuccui has made substantial contributions to the scientific community. His work at the London School of Hygiene and Tropical Medicine has positioned him as a leader in vaccine research. He has dedicated his career to understanding and developing new methods to prevent infectious diseases.

Collaborations

Jon Cuccui has collaborated with esteemed colleagues such as Brendan Wren and Jeremy Brown. These partnerships have fostered a collaborative environment that enhances the research output and innovation in vaccine development.

Conclusion

In summary, Jon Cuccui is a distinguished inventor whose work in Glyconjugate Vaccines has made a significant impact on public health. His dedication to research and collaboration continues to drive advancements in the field of vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…